In an effort to elucidate why BCA2 performs opposite roles in the regulation of IRF1, we performed mechanistic studies that revealed that in ER+ cell lines BCA2 physically interacts with IRF1 to enhance its translocation to the nucleus, which consequently would facilitate the expression of anti-tumor effectors. This evidence concerns the gene IRF1 and neoplasm.